125 related articles for article (PubMed ID: 37500336)
1. Quantitative image features of gadoxetic acid-enhanced MRI for predicting glypican-3 expression of small hepatocellular carcinoma ≤3 cm.
Dong SY; Sun W; Xu B; Wang WT; Yang YT; Chen XS; Zeng MS; Rao SX
Clin Radiol; 2023 Oct; 78(10):e764-e772. PubMed ID: 37500336
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
[TBL] [Abstract][Full Text] [Related]
3. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
[TBL] [Abstract][Full Text] [Related]
4. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
[TBL] [Abstract][Full Text] [Related]
6. Significance of the Signal Intensity of Gadoxetic Acid-enhanced MR Imaging for Predicting the Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma.
Fujita N; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Morita K; Shirabe K; Koto K; Kubo Y; Oda Y; Honda H
Magn Reson Med Sci; 2016; 15(1):111-20. PubMed ID: 26346403
[TBL] [Abstract][Full Text] [Related]
7. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
8. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
Dong SY; Wang WT; Chen XS; Yang YT; Zhu S; Zeng MS; Rao SX
Eur Radiol; 2022 Jun; 32(6):4198-4209. PubMed ID: 35079885
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Glypican-3 Expression in Hepatocellular Carcinoma by Using IDEAL IQ Magnetic Resonance Imaging.
Chen R; Bai Y; Liu T; Zhang G; Han Y; Chen L; Gao H; Wei W; Wang M
Acad Radiol; 2021 Aug; 28(8):e227-e234. PubMed ID: 32540197
[TBL] [Abstract][Full Text] [Related]
10. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
11. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
[TBL] [Abstract][Full Text] [Related]
12. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
13. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
[TBL] [Abstract][Full Text] [Related]
15. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
16. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
Li N; Dong T; Wang P; Li Q; Nie F
Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
[TBL] [Abstract][Full Text] [Related]
17. [Study of magnetic resonance imaging based on liver imaging reporting and data system for evaluating phosphatidylinositol proteoglycan-3 expression in hepatocellular carcinoma].
Sun W; Zhao JT; Gao SS; Han J; Sheng RF; Zeng M
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):866-872. PubMed ID: 36207943
[No Abstract] [Full Text] [Related]
18. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
19. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
[TBL] [Abstract][Full Text] [Related]
20. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
